Prostate Cancer - Results from #160

Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment. May 25, 2022

ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer. May 24, 2022

Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost-utility analysis alongside a randomized HYPO-RT-PC trial. May 24, 2022

The growing role of rucaparib in contemporary treatment of metastatic prostate cancer: a review of efficacy and guidance for side effect management. May 24, 2022

PI-RADS: multiparametric MRI in prostate cancer. May 24, 2022

Overcoming Immune Resistance With Radiation Therapy in Prostate Cancer. May 24, 2022

Management Impact of Metachronous Oligometastatic Disease Identified on 18F-Fluciclovine (Axumin™) PET/CT in Biochemically Recurrent Prostate Cancer. May 24, 2022

Prostate cancer addiction to oxidative stress defines sensitivity to anti-tumor neutrophils. May 24, 2022

Primary care-based follow-up for prostate and kidney cancer survivors: a retrospective monocentric study. May 24, 2022

Morbidity of salvage radical prostatectomy: limited impact of the minimally invasive approach. May 23, 2022

Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis. May 23, 2022

Racial and Ethnic Differences in Rural-Urban Trends in 5-Year Survival of Patients With Lung, Prostate, Breast, and Colorectal Cancers: 1975-2011 Surveillance, Epidemiology, and End Results (SEER). May 23, 2022

Plain language summary of the HERO study comparing relugolix with leuprolide for men with advanced prostate cancer. May 23, 2022

Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium. May 23, 2022

Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation Study. May 20, 2022

Mobile Clinical Trial Matching Technology in Medical Oncology Clinic: A Pilot Feasibility Study. May 20, 2022

Nationwide Industry-Led Community Exercise Program for Men With Locally Advanced, Relapsed, or Metastatic Prostate Cancer on Androgen-Deprivation Therapy. May 20, 2022

Penalized weighted proportional hazards model for robust variable selection and outlier detection. May 20, 2022

Quality of life in low-income men after surgical castration for metastatic prostate cancer. May 20, 2022

Embracing the Practical Aspects of Theranostics With Prostate-Specific Membrane Antigen–Targeted Lutetium-177 May 19, 2022

Page 9 of 1232

email news signup